- Home
- FIZZ vs RNA Comparison
FIZZ vs RNA Comparison
Compare FIZZ & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIZZ
- RNA
- Stock Information
- Founded
- FIZZ 1985
- RNA 2012
- Country
- FIZZ United States
- RNA United States
- Employees
- FIZZ N/A
- RNA N/A
- Industry
- FIZZ Beverages (Production/Distribution)
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- FIZZ Consumer Staples
- RNA Health Care
- Exchange
- FIZZ Nasdaq
- RNA Nasdaq
- Market Cap
- FIZZ 3.1B
- RNA 4.0B
- IPO Year
- FIZZ 1991
- RNA 2020
- Fundamental
- Price
- FIZZ $32.78
- RNA $70.94
- Analyst Decision
- FIZZ Strong Sell
- RNA Buy
- Analyst Count
- FIZZ 1
- RNA 20
- Target Price
- FIZZ $39.00
- RNA $69.26
- AVG Volume (30 Days)
- FIZZ 338.9K
- RNA 10.1M
- Earning Date
- FIZZ 12-04-2025
- RNA 11-10-2025
- Dividend Yield
- FIZZ N/A
- RNA N/A
- EPS Growth
- FIZZ 0.66
- RNA N/A
- EPS
- FIZZ 1.98
- RNA N/A
- Revenue
- FIZZ $1,202,396,000.00
- RNA $20,868,000.00
- Revenue This Year
- FIZZ $2.80
- RNA N/A
- Revenue Next Year
- FIZZ $2.19
- RNA $108.97
- P/E Ratio
- FIZZ $16.57
- RNA N/A
- Revenue Growth
- FIZZ 0.46
- RNA 106.27
- 52 Week Low
- FIZZ $32.21
- RNA $21.51
- 52 Week High
- FIZZ $50.51
- RNA $70.98
- Technical
- Relative Strength Index (RSI)
- FIZZ 33.87
- RNA 80.61
- Support Level
- FIZZ $32.68
- RNA $69.67
- Resistance Level
- FIZZ $33.83
- RNA $70.98
- Average True Range (ATR)
- FIZZ 0.99
- RNA 0.40
- MACD
- FIZZ 0.06
- RNA -0.05
- Stochastic Oscillator
- FIZZ 13.13
- RNA 55.49
About FIZZ National Beverage Corp.
National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.